NYSE: MRK
Merck & Co Inc Stock

$85.20+0.49 (+0.58%)
Updated Apr 30, 2025
MRK Price
$85.20
Fair Value Price
N/A
Market Cap
$215.22B
52 Week Low
$75.93
52 Week High
$134.63
P/E
12.6x
P/B
4.65x
P/S
3.93x
PEG
0.75x
Dividend Yield
3.71%
Revenue
$64.17B
Earnings
$17.12B
Gross Margin
76.3%
Operating Margin
33.02%
Profit Margin
26.7%
Debt to Equity
1.53
Operating Cash Flow
$21B
Beta
0.32
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

MRK Overview

Merck & Company Incorporated develops and distributes prescription medicines, vaccines, biologic therapies, and animal health products. Merck & Co. was founded in 1891 and is headquartered in Kenilworth, NJ.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine MRK's potential to beat the market

CHold
  • Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More

Zen Rating Component Grades

B
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: General Drug Manufacturer

Industry Rating
A
MRK
Ranked
#14 of 18

Top Ranked Stocks in Industry

View Top General Drug Manufacturer Stocks

Be the first to know about important MRK news, forecast changes, insider trades & much more!

MRK News

Overview

Due Diligence Score

Industry Average (40)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how MRK scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

MRK ($85.20) is trading above its intrinsic value of $79.10, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
MRK is good value based on its earnings relative to its share price (12.6x), compared to the US market average (29.18x)
P/E vs Market Valuation
MRK is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more MRK due diligence checks available for Premium users.

Valuation

MRK price to earnings (PE)

For valuing profitable companies with steady earnings

Company
12.6x
Industry
54.95x
Market
29.18x
MRK is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
MRK is good value based... subscribe to Premium to read more.
P/E vs Market Valuation

MRK price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
4.65x
Industry
6.33x
MRK is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

MRK price to earnings growth (PEG)

For valuing profitable companies with growth potential

MRK is good value based... subscribe to Premium to read more.
PEG Value Valuation

MRK's financial health

Profit margin

Revenue
$15.6B
Net Income
$3.7B
Profit Margin
24%
MRK's Earnings (EBIT) of $21.19B... subscribe to Premium to read more.
Interest Coverage Financials
MRK's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$117.1B
Liabilities
$70.7B
Debt to equity
1.53
MRK's short-term assets ($38.78B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
MRK's long-term liabilities ($42.31B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
MRK's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
MRK's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$3.5B
Investing
-$1.4B
Financing
-$3.0B
MRK's operating cash flow ($21.47B)... subscribe to Premium to read more.
Debt Coverage Financials

MRK vs General Drug Manufacturer Stocks

TickerZen RatingMarket Cap1d %P/EP/B
MRKC$215.22B+0.58%12.60x4.65x
NVSB$222.36B+0.04%17.62x5.80x
AZNB$222.55B+0.11%28.66x5.42x
AMGNC$156.28B+0.82%38.18x26.59x
SNYC$138.82B+2.29%23.76x1.72x

Merck & Co Stock FAQ

What is Merck & Co's quote symbol?

(NYSE: MRK) Merck & Co trades on the NYSE under the ticker symbol MRK. Merck & Co stock quotes can also be displayed as NYSE: MRK.

If you're new to stock investing, here's how to buy Merck & Co stock.

What is the 52 week high and low for Merck & Co (NYSE: MRK)?

(NYSE: MRK) Merck & Co's 52-week high was $134.63, and its 52-week low was $75.93. It is currently -36.72% from its 52-week high and 12.21% from its 52-week low.

How much is Merck & Co stock worth today?

(NYSE: MRK) Merck & Co currently has 2,526,036,240 outstanding shares. With Merck & Co stock trading at $85.20 per share, the total value of Merck & Co stock (market capitalization) is $215.22B.

Merck & Co stock was originally listed at a price of $53.00 in Dec 31, 1997. If you had invested in Merck & Co stock at $53.00, your return over the last 27 years would have been 60.75%, for an annualized return of 1.77% (not including any dividends or dividend reinvestments).

How much is Merck & Co's stock price per share?

(NYSE: MRK) Merck & Co stock price per share is $85.20 today (as of Apr 30, 2025).

What is Merck & Co's Market Cap?

(NYSE: MRK) Merck & Co's market cap is $215.22B, as of May 2, 2025.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Merck & Co's market cap is calculated by multiplying MRK's current stock price of $85.20 by MRK's total outstanding shares of 2,526,036,240.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.